Active, not recruitingPHASE1, PHASE2NCT04967170

A Study to Evaluate Platelet Rich Plasma to Treat Vulvar Lichen Sclerosus

Studying Rapidly involuting congenital hemangioma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Jennifer R. Arthurs
Principal Investigator
Katherine Bodiford, MD
Mayo Clinic
Intervention
Autologous Platelet-Rich Plasma (PRP)(biological)
Enrollment
30 target
Eligibility
18 years · FEMALE
Timeline
20222026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04967170 on ClinicalTrials.gov

Other trials for Rapidly involuting congenital hemangioma

Additional recruiting or active studies for the same condition.

See all trials for Rapidly involuting congenital hemangioma

← Back to all trials